Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.

J Clin Endocrinol Metab 2004;89:2601-07

Carr MC, Brunzell JD

Description

Two common oligogenic disorders account for about half the coronary artery disease (CAD) risk associated with the metabolic syndrome in premature CAD.

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.

J Clin Endocrinol Metab 2004;89:2601-07

Description

Categories